Adjunct instructor with the Master's of Medical Device Innovation program:*MDI 5012 (Medical Industry Strategic Analysis): Fall 2022*MDI 5010 (Product Development and Innovation Management): Fall 2022-present*MDI 5020 (Medical Device Innovation Capstone): Fall 2022-2024

Consultancy created to fulfill market need for marketing/commercialization and program management consulting for medical device manufacturing clients.

Developed, implemented, and managed process for drafting and submitting 15 NIH SBIR/STTR grants with investigators across Colleges of Medicine, Pharmacy, Nursing, and Engineering.

Instructor for Medical Industry Leadership Institute (MILI) Valuation Lab, leading graduate student teams through evaluation of early-stage medical device, pharmaceutical, and biotechnology ventures for go/no-go decision on investment.Advised graduate student team on targeted marketing research project for leading medical device manufacturer through Bakken Medical Devices Center (BMDC).

Led team of two project managers in managing site portfolio of R&D and operations projects in pre- and post-BLA environment.

SynerFuse™ is an early-stage company whose goal is to help people live without pain by making traditional spine implant surgery more successful and cost effective. This is done by combining neuromodulation at the time surgeons are performing fusion back surgery. Managed upstream and downstream marketing activities and related vendors, including commercialization strategy and plan through initial product launch and communications strategy (with production and release of shareholder communications, press releases, and investor documents). Led effort for selecting reimbursement strategy firm and managed strategy development scoping and execution with key stakeholders including reimbursement, business development, finance, executive, and data science.

Managed upstream and downstream marketing activities and non-dilutive funding for transcutaneous energy transmission platform for use in ventricular assist devices, resulting in $1M licensure deal.Conducted upstream marketing activities and KOL organization for greenfield Class III medical device in $200M neurocritical care indication through IDE submission.Evaluated follow-on indication for new neurocritical care device and executed plan to reduce time-to-market into $30M orphan device market using public funding.Managed and performed go/no-go analysis, defined requirements, set pricing, and managed marketing efforts for remote connectivity platform through launch, including closing term sheet with first customer for $650K in ongoing annual revenue at operating margin above company average.Served as commercial lead for research group (Neurapheresis Research Consortium) and organized content/schedule for first annual meeting, resulting in improved cross-indication collaboration and new opportunities for clinical research.Managed two medical device development projects funded through $3.2M in federal grants, including R&D and pre-clinical development efforts, to within 5% of budget.Led industrial design projects with key stakeholders including engineering and executive leadership team for aftermarket ventricular assist device controller licensed to industry leader for est. $1M.Managed writing, assembly, submission, and administration of 11 federal small business grants, raising $20.7M in non-dilutive funding for R&D and clinical trial activities.

Managed team of six graduate student fellows in developing business plan to provide ongoing revenue streams to MILI and BMDC Fellows.Evaluated technologies from five clinical areas developed by the BMDC Fellows with goal of securing exits via licensing sale or start-up formation, analyzing market, financial, technical, intellectual property, regulatory, voice of customer, and manufacturing aspects.Pitched BMDC technology to venture capital community to secure intellectual property sale.

Managed launch of small-business remote deposit capture product with key stakeholders from business line and development staff.Planned and coordinated migration of 850 remote deposit capture software customers to new release with key stakeholders including development group and sales.

Managed multiple telecommunication product lines with combined annual revenue of $7.8M, growing market penetration in cable TV (CATV) customer base by 15%.Secured OEM agreement on telecommunication product line with key equipment manufacturer, leading to 20% in additional revenue.Developed training and marketing materials based on common customer applications and differentiators for key products to increase mindshare and market presence in CATV market.Created acquisition strategy to accelerate growth in existing domestic and international markets.

Managed telecommunication test system product portfolio with annual revenue of $7.6M, including development of new option for residential DSL testing through first office application.

Managed telecommunication test product lines with annual revenue of $25M, including sales support, forecasting, product margin management, customer outreach, and end-of-life process